about
The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agentsInsulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunitIGF binding proteins in cancer: mechanistic and clinical insightsPotentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activityThe role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayersCellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complexInsulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domainInhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3Age-dependent regulation of the acid-labile subunit in response to fasting-refeeding in ratsN-Linked glycosylation and sialylation of the acid-labile subunit. Role in complex formation with insulin-like growth factor (IGF)-binding protein-3 and the IGFsLigand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labelingContinuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: a randomized sham-controlled study.Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.Tissue biomarkers of breast cancer and their association with conventional pathologic features.Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines.Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry.Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry.Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes.Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.The insulin-like growth factor (IGF)-IGF-binding protein axis in critical illness.Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.How should insulin-like growth factor I be measured? A consensus statement.Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinomaRapamycin treatment for a child with germline PTEN mutation.Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts.Gonadotropin signalling in epithelial ovarian cancer.The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopy.Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells.Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.iTRAQ-based proteomic profiling of breast cancer cell response to doxorubicin and TRAIL.Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells.The in vivo phosphorylation and glycosylation of human insulin-like growth factor-binding protein-5.
P50
Q24304487-7A332229-236B-445F-99CF-E7E7CBA0B2E5Q24316404-FA5064AC-3888-4459-B492-EAD3CDF5FC86Q28237971-D911AD01-6A8D-4D75-B250-B6B2990A9F3BQ28253045-7C4B1933-A0AC-4EEF-9711-23A7CAFAEF5DQ28260282-C4DDC82C-637A-4F0D-93D1-73FB54F7DBF8Q28286146-EA6F537A-9AB8-4820-AD24-0BE838DB44C2Q28286453-6F7D8EDB-4B6D-4CE5-9345-EFFA97BC7E6AQ28306711-6EA0AB55-8854-4E4E-8FDA-6C8FC4462544Q28570147-0B15F8B2-D3AE-4DA7-966D-EBAB380F2DE2Q28616473-368FD4D1-E10C-43E2-A10C-FF4AC983180EQ28616682-364AC933-FAAB-4341-BDE2-1929D32FD050Q28618442-33062928-3F7C-4D88-B288-F793BB04EE05Q30410531-5B388B8D-44F0-45EE-99B8-C260A18E4D5DQ30823098-21B5C325-6BE1-47A5-A76F-7CE4ED89A5A3Q31110635-28E04397-19CB-4E10-8B31-6760BFE31501Q33232865-0047C161-5991-4D00-90FE-6A4A86E4499DQ33243318-521D645B-7AAA-4E3E-9B5F-43D73A37C479Q33291040-A50E2052-7DC6-411F-A7D3-C8927D5D8F6DQ33296143-F954324D-08FF-4368-99F4-AECCA4C820A2Q33459006-F786AF1D-D48D-4813-BABB-96BB044B70C6Q33620112-B7E9A6E0-FC31-480D-9D85-185D15234F75Q33701434-9F3D9130-C5FD-4004-B405-65448814C6F0Q33888618-E10C8176-6DD4-42C6-A5BA-0F34FF39523BQ33892389-EC548356-3A1A-4ED4-8A5B-CF8E577F9A4FQ34022792-05EDE8AD-57A4-4EA0-87D6-86ACC0F737E5Q34225996-85CE689A-8E56-4ED8-B35A-A7BDD10AD7F9Q34335696-8EA22499-966D-48F7-8694-2E117EF77DBDQ34422186-AC7832BE-15E9-4CB3-993D-64E0A9047882Q34483897-4468FA89-4F37-418D-B86A-0A07F789A51EQ34773159-7C00241E-7DBB-417C-84BE-DE9E1D25B8BBQ37612032-A71F2F42-9791-4037-8BA3-958DEB5DB815Q38013514-8A2C9016-1DF1-4124-B07C-C457A6D27BB3Q38321959-7AE5825F-FB3A-47E8-B14B-F6508C3C9565Q38335404-1D737EFE-FD9E-49D9-9239-E5CC618B7971Q38675999-711CDC31-0FA2-4209-91D0-6BCB8557FE89Q39043513-D2800E5D-D702-4CAD-A2B2-5A07ECB123A6Q39348034-B347330E-DDEF-40CA-9F09-E8AF72A283D7Q39434596-B5F994B1-7FF1-4A66-829B-FB177BA8217BQ39773767-BA85ACFB-5664-4D79-BBB0-5D9DF3109472Q40133971-B333E287-9A56-44B4-BC44-517B57D7E1B5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Robert C Baxter
@ast
Robert C Baxter
@en
Robert C Baxter
@es
Robert C Baxter
@sl
type
label
Robert C Baxter
@ast
Robert C Baxter
@en
Robert C Baxter
@es
Robert C Baxter
@sl
altLabel
Rob Baxter
@en
Robert Charles Baxter
@en
prefLabel
Robert C Baxter
@ast
Robert C Baxter
@en
Robert C Baxter
@es
Robert C Baxter
@sl
P1006
P214
P244
P1006
P1053
F-3927-2012
P106
P21
P213
0000 0000 7704 7959
P214
P244
P31
P3829
P496
0000-0001-5061-2142
P734
P735
P7859
lccn-n94801189